Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

McGill University

$27,000.00

Genetic dissection of coronary artery disease heterogeneity for drug target discovery and precision medicine

FY 2025-26

Summary
Coronary artery disease (CAD) is a prevalent heart condition that remains the leading cause of morbidity and mortality in Canada and worldwide. It is a heterogeneous disease, meaning it is driven by a variety of biological processes that manifest differently between individuals, including abnormalities in lipids, blood pressure, and blood vessel function and remodelling. Some of these processes are not fully understood and untargeted by current therapeutics, leaving a need for more in-depth characterization. To this end, our research will leverage a technique called genetic clustering to define underlying CAD subtypes. First, we use existing large genetic datasets to find common DNA variations that contribute to CAD risk. We then group them together using a clustering algorithm based on how they affect other cardiometabolic traits (e.g. BMI or blood pressure). We expect the resulting clusters to reflect biologically relevant CAD subtypes. To follow up, we will identify the genes and cells associated with each cluster, anchoring our results in real biology and hinting at possible drug targets. Finally, we will develop a genetic risk score to quantify each cluster’s contribution to CAD risk in individuals. This enables us to match patients to their risk-driving subtypes. We will examine whether these risks differ between sexes. In practice, this can enable clearer diagnosis and more targeted prevention and therapy. Ultimately, our research aims to define and characterize CAD subtypes as well as develop risk scores to promote personalized CAD prevention and treatment.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
572548
Name
Smith Leighton
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Genetic dissection of coronary artery disease heterogeneity for drug target discovery and precision medicine
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Bayesian Non-Negative Matrix Factorization; Bioinformatics; Characterization; Complex Metabolic Diseases; Coronary Artery Disease; Disease Heterogeneity; Genetic Clustering; Genetic Risk Scores; Genomics Data; Programming
Abstract
Coronary artery disease (CAD) is a prevalent heart condition that remains the leading cause of morbidity and mortality in Canada and worldwide. It is a heterogeneous disease, meaning it is driven by a variety of biological processes that manifest differently between individuals, including abnormalities in lipids, blood pressure, and blood vessel function and remodelling. Some of these processes are not fully understood and untargeted by current therapeutics, leaving a need for more in-depth characterization. To this end, our research will leverage a technique called genetic clustering to define underlying CAD subtypes. First, we use existing large genetic datasets to find common DNA variations that contribute to CAD risk. We then group them together using a clustering algorithm based on how they affect other cardiometabolic traits (e.g. BMI or blood pressure). We expect the resulting clusters to reflect biologically relevant CAD subtypes. To follow up, we will identify the genes and cells associated with each cluster, anchoring our results in real biology and hinting at possible drug targets. Finally, we will develop a genetic risk score to quantify each cluster’s contribution to CAD risk in individuals. This enables us to match patients to their risk-driving subtypes. We will examine whether these risks differ between sexes. In practice, this can enable clearer diagnosis and more targeted prevention and therapy. Ultimately, our research aims to define and characterize CAD subtypes as well as develop risk scores to promote personalized CAD prevention and treatment.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Smith, Leighton
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~